CompletedN/Aketamine
Esketamine vs Remimazolam for Postoperative Sleep Disturbance and Anxiety
Sponsored by Tianjin Medical University General Hospital
NCT ID
NCT06284668
Target Enrollment
315 participants
Start Date
2024-03-04
Est. Completion
2025-05-20
About This Study
To explore and compare the effects of esketamine and remimazolam on postoperative sleep disturbance in patients undergoing oocyte retrieval
Conditions Studied
Interventions
- •normal Saline
- •Esketamine
- •Remimazolam
Eligibility
Sex:FEMALE
Age:18 Years - 45 Years
Healthy Volunteers:No
View full eligibility criteria
Inclusion Criteria: 1. Age 18-45 years old; 2. American society of Aneshesiologists(ASA)physical status classification system is grade I-III; 3. Elective surgery is proposed 4. BMI of 19-30 kg/m2; 5. Patients who agreed to enroll in this study voluntarily Exclusion Criteria: 1. Those who are known to be allergic to the drug ingredients in this study and their allergic constitution; 2. Allergic history of general anesthesia drugs, opioid drugs, non-steroidal drugs; 3. History of neurological diseases; History of chronic pain; Drug and alcohol addiction; A long history of opioid use; Opiates were given 48 hours before surgery 4. Coronary heart disease, bronchial asthma, severe hypertension, severe blood system dysfunction, liver and kidney function, electrolyte abnormalities; 5. Respiratory insufficiency, respiratory failure; 6. BMI\<18 kg/m2 or BMI\>30kg/m2; 7. Poor compliance, unable to complete the experiment according to the study plan; Participants who have participated in clinical trials of other drugs within the last 4 weeks; 8. Preoperative Pittsburgh Sleep Quality Index (PSQI) higher than 7 9. Any circumstances deemed unsuitable for inclusion by the researcher for any reason.
Study Locations (1)
Tianjin Medical University General Hospital
Tianjin, China